Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study

Name: Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study
License: Public Domain

Hasten Biopharmaceutical Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

essential hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 141130
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.